| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Animal Model |
From the Department of Pathology, University of Texas Medical Branch, Galveston, Texas
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
HME is a multisystemic disease with clinical manifestations that range from mild to severe illness, and a mortality rate of 3 to 4% despite the excellent efficacy of doxycycline treatment.7-11 HME can affect previously healthy, immunocompetent patients or severely immunocompromised patients (eg, acquired immune deficiency syndrome) in whom the infection is often overwhelming.12 More than 740 cases and 1,500 cases have been confirmed at the Centers for Disease Control and Prevention and at a large reference laboratory (MRL Diagnostics, Cypress, CA), respectively, totaling more than 2,200 cases of HME diagnosed in 47 states.11,13 The epidemiological importance of this disease is highlighted by an on-going prospective study in Cape Girardeau in southeastern Missouri, where the provisional incidence was 11 cases per 100,000 population in 1998.11 This figure is most likely an underestimate because one primary care physicians office practice accounted for the majority of cases. Other studies have shown that HME is even more prevalent than Rocky Mountain spotted fever in states such as North Carolina where Rocky Mountain spotted fever is highly endemic.14
The currently available animal models of E. chaffeensis infection are unsatisfactory. Several reports of inoculation of E. chaffeensis into immunocompetent mice, ie, BALB/c, C3H/HeJ, C.B-17, C3H/HeN, DBA, and C57BL/6 have shown resistance to the development of disease.15-19 The presence of the organism in the tissues and blood after inoculation was detected only by polymerase chain reaction amplification of ehrlichial DNA genes after inoculation. Seroconversion occurs several days after inoculation of the animals with E. chaffeensis, but few of the animals develop any illness, and none die. Furthermore, the animals do not develop histopathological lesions mimicking the disease in humans. For the above reasons, these animal models are inadequate for the study of HME. The inoculation of E. chaffeensis into immunocompromised mice, ie, SCID mice, produces severe disease with fatal outcome.18,19 However, this model is far from ideal because of development of histopathological lesions that do not resemble the lesions observed in humans. Furthermore, the use of immunocompromised animals is a very unrealistic model to study the evolution and development of the immunological events of the disease.
Alternatively, the infection caused by Ehrlichia muris, an ehrlichia genetically closely related to E. chaffeensis, in immunocompetent mice, ie, BALB/c mice, causes disseminated infection associated with mild disease and minimal mortality.20 The absence of death or severe disease are major drawbacks of this model for investigating pathogenesis and protective immunity.
Ehrlichia canis infection causes disease in dogs with histopathological lesions during the acute stage similar to those of HME.21-24 However, the absence of inbred syngeneic dogs, including animals with genetically defined immune defects, the lack of data on the sequence of events during the host defense responses in dogs, and the lack of commercially available canine-specific markers for immune effectors are significant limitations of this model.
Thus, the need for a better animal model to study HME is of utmost importance. The ideal animal model would use E. chaffeensis or a closely related ehrlichia with the capacity to produce severe disease and death in immunocompetent animals. The histopathological lesions should be similar to the lesions observed in HME, and the severity of disease and lethality should be predictable based on the dose of inoculum.
In the present study, we report the histopathological findings of an excellent animal model for HME. C57BL/6 mice were inoculated with an ehrlichial organism [Ixodes ovatus ehrlichia (IOE), strain HF565] isolated from I. ovatus ticks in Japan.25 IOE is closely related genetically to E. chaffeensis by 16S rRNA sequence analysis.26 It has also been demonstrated that the sequences of the p28 multigene family of IOE are closely related to E. chaffeensis, E. muris, and E. canis (JW McBride and X-J Yu, unpublished data). Furthermore, there is a close antigenic relationship of the E. chaffeensis p28 and cell wall components of IOE as demonstrated by immuno-ultrastructural studies of the reactivity of monoclonal antibodies to E. chaffeensis p28 against the outer aspect of the cell wall of IOE (JW McBride and VL Popov, unpublished data).
| Materials and Methods |
|---|
|
|
|---|
Liver and spleen harvested from ddY mice inoculated with IOE were received frozen on dry-ice as a generous gift from Dr. Makoto Kawahara, Microbiology Department, Nagoya City Public Health Research Institute, Nagoya, Japan. The organs were weighed and ground in toto at a 10% w/v concentration in sucrose-phosphate-glutamate buffer (0.218 mol/L sucrose, 0.0038 mol/L KH2PO4, 0.0072 mol/L K2HPO4, 0.0049 mol/L monosodium glutamic acid, pH 7.0). To produce ehrlichial stocks for reproducible studies throughout a long period of investigation, 10 C57BL/6 mice were inoculated intraperitoneally with 1 ml of the suspension. On days 10 and 11 after inoculation, the mice were sacrificed, and the spleens and livers were harvested. The organs were then weighed, and a 10% w/v suspension was prepared by homogenizing the organs in sucrose-phosphate-glutamate buffer. Large particles of debris were removed by centrifugation at 190 x g for 3 minutes. The supernatant was then aliquoted and stored at -80°C as 10-1 stock of IOE. Quantitation of the organisms was not performed because of the lack of a precise method to do so. However, the LD50 of this stock was approximately a dilution of 10-5, because a 10-4 dilution killed 100% of the mice and 100% of the mice survived when inoculated with 10-6 of the same stock (unpublished data).
Mice
Ten C57BL/6 inbred mice were obtained from the Jackson Laboratory (Bar Harbor, ME). All mice were male and 6 to 8 weeks old.
Infection of Mice
Eight mice were inoculated intraperitoneally with 1 ml of a 10-4 dilution of the IOE stock suspension. Two control animals were inoculated intraperitoneally with 1 ml of a 10-4 dilution of a homogenate of uninfected spleen and liver. Two infected mice were sacrificed on each of days 2, 5, 7, and 9 after inoculation. The two control mice were sacrificed on day 10 after inoculation. A complete necropsy was performed on each of the animals.
Histology and Immunohistochemistry
The liver, spleen, bone marrow, kidneys, testis, skeletal muscle, and lungs were fixed in 4% neutral-buffered formaldehyde, embedded in paraffin, and stained with hematoxylin and eosin. Paraffin-embedded sections of the liver from two mice sacrificed on day 9 after inoculation were stained by Massons trichrome and reticulin methods.
Tissue sections of liver, spleen, bone marrow, and lungs from all of the animals were stained immunohistochemically using an automated Ventana ES Immunostainer (Ventana Medical Systems, Tucson, AZ). Briefly, the sections were deparaffinized by heating the glass slides at 70°C for 20 minutes, followed by immersion in three xylene baths for 5 minutes each. The slides were then rehydrated by immersion in a series of alcohol baths ranging from 100 to 80% for 3 minutes each. The slides were then washed in distilled water and placed in Ventana Medical Systems wash solution until they were loaded on the instrument for staining. The slides were then incubated with an endogenous peroxidase inhibitor solution containing hydrogen peroxide and sodium azide (Ventana Medical Systems) for 4 minutes at 37°C followed by incubation with anti-E. chaffeensis rabbit polyclonal antibody for 32 minutes at 37°C. The slides were then washed in phosphate-buffered saline (PBS) and incubated for 8 minutes with a goat biotinylated anti-rabbit IgG (H + L) antibody (Vector Laboratories, Burlingame, CA). The slides were then washed and incubated with avidin-horseradish peroxidase conjugate for 8 minutes at 37°C, followed by incubation with a substrate solution containing 3-amino-9-ethylcarbazole for 8 minutes at 37°C. Counterstaining with hematoxylin was then performed, and the slides were coverslipped. Normal rabbit serum was used as primary antibody as a negative control.
Electron Microscopy
One cubic millimeter pieces of liver, spleen, and lungs were obtained from all experimental animals and fixed in a mixture of 1.25% formaldehyde, 2.5% glutaraldehyde, and 0.03% trinitrophenol in 0.05 mol/L cacodylate buffer, postfixed in 1% osmium tetroxide in the same buffer, stained en bloc in 1% uranyl acetate in 0.1 mol/L maleate buffer, and processed further as described previously,27 until embedded in Poly/Bed 812 (Polysciences Inc., Warrington, PA). Ultrathin sections were cut with a Reichert Ultracut S ultramicrotome (Leica Instruments, Deerfield, IL), stained with aqueous uranyl acetate and lead citrate and examined in a Philips CM100 electron microscope (Philips Electron Optics, Eindhoven, The Netherlands) at 60 kV.
Terminal dUTP Nick-End Labeling (TUNEL) Stain
The tissue sections were deparaffinized as described above. The tissue was then permeabilized by covering the entire specimen with a 20 µg/ml solution of proteinase K diluted in 10 mmol/L Tris, pH 8, and incubated for 20 minutes at room temperature. The tissue sections were then washed in Tris-buffered saline (20 mmol/L Tris, 140 mmol/L NaCl, pH 7.6). Inactivation of endogenous peroxidases was accomplished by immersing the tissue sections in 3% hydrogen peroxide diluted in methanol for 5 minutes at room temperature. The glass slides were then placed in equilibration buffer (1 mol/L sodium cacodylate, 0.15 mol/L Tris, 1.5 mg/ml bovine serum albumin, 3.75 mmol/L CaCl2, pH 6.6) for 30 minutes. The tissue sections were then incubated with 60 µl of a solution containing terminal deoxynucleotidyl transferase and a mixture of biotinylated dNTPs, according to the manufacturers instructions (terminal deoxynucleotidyl transferase-Fragel; Oncogene Research Products, Cambridge, MA) at 37°C for 90 minutes in a hybridization chamber (Hybri-Well; Sigma Chemical Co., St. Louis, MO). The enzymatic reaction was stopped by incubation with 0.5 mol/L ethylenediaminetetraacetic acid, pH 8, for 5 minutes at room temperature. The slides were then washed with Tris-buffered saline and immersed in blocking buffer for 20 minutes (4% bovine serum albumin in PBS) followed by incubation with 100 µl of a solution containing peroxidase-streptavidin for 30 minutes at room temperature in a humidified chamber according to the manufacturers instructions (Oncogene Research Products). The tissue sections were then washed in Tris-buffered saline and covered with a solution containing 3,3' diaminobenzidine (0.7 mg/ml), hydrogen peroxide and urea (0.6 mg/ml). The slides were then rinsed with distilled water and counterstained with Azure A for 10 seconds. Positive controls were generated by digesting the tissue sections with DNase I (10 µg/ml final concentration) in Tris-buffered saline containing 1 mmol/L MgCl2 for 20 minutes. Terminal deoxynucleotidyl transferase was omitted in slides used as negative controls. A different set of slides from the same animals was also double-stained by the TUNEL method for apoptosis and by immunohistochemistry with the ehrlichial antibodies described earlier. However, detection of the ehrlichial organisms was performed with alkaline-phosphatase-tagged secondary antibodies (Vector Laboratories, Inc.) and Fast Red as a substrate for color development for optimal distinguishing of the ehrlichial organisms and apoptosis.
Blood Counts
Blood samples from infected and control mice were processed through a Sysmex SE-9000 TOA Medical Electronics Co., Ltd. (Kobe, Japan) automated analyzer for total and differential white blood cell counts, red blood cell counts, and platelet counts.
Serum Evaluation of Hepatic Injury and Function
Serum samples from infected mice on days 2, 5, 7, and 9 and uninfected control animals were assayed in a Vitros Chemistry System 950 Johnson and Johnson Clinical Diagnostics (Rochester, NY) automated analyzer for the hepatic transaminases, alanine and aspartate amino-transaminases, alkaline phosphatase, and total bilirubin concentrations.
Antibody Responses
Serum samples from infected and control mice were measured by indirect immunofluorescence assay using E. muris as a surrogate antigen. Antigen slides were prepared as follows: monolayers of DH82 cells were grown in 150 cm2 flasks in Dulbeccos modified Eagles medium containing 5% fetal bovine serum. Infection of the monolayer was monitored by Diff Quik staining until 80% of the cells were infected. The cells were harvested, and antigen slides were prepared. Serum samples were serially diluted twofold and incubated with the antigen slides for 30 minutes at 37°C in a humidified chamber. The antigen slides were then washed three times in PBS, pH 7.4, and then incubated with fluorescein isothiocyanate-labeled anti-mouse immunoglobulins (Kirkegaarde and Perry, Gaithersburg, MD) at a 1:100 dilution. The slides were then washed three times in PBS, pH 7.4, counterstained with Evans blue and examined under a Nikon Labphoto fluorescent microscope (Nikon Co., Tokyo, Japan). Serological titers were expressed as the reciprocal of the highest dilution at which specific fluorescence was detected.
| Results |
|---|
|
|
|---|
All animals developed severe sickness with ruffled fur, inactivity, and huddling together on day 7 and died on day 9.
Histopathological Observations
The liver, spleen, bone marrow, and lungs were evaluated in detail because these were the organs that showed the most consistent and remarkable changes.
Moderate diffuse ballooning cell injury of hepatocytes and mild Kupffer
cell hyperplasia were observed on day 2. Occasional focal collections
of mostly neutrophils and scattered macrophages, which were present
mostly in the midzonal area of the hepatic lobule, were identified in
mice inoculated with either uninfected or infected liver-spleen
homogenate. Thus they were not considered to be related to the
ehrlichial infection. On day 5, occasional apparent apoptotic bodies
were observed associated with focal accumulations of macrophages, and
diffuse ballooning cell injury of hepatocytes persisted. On day 7, the
Kupffer cell hyperplasia had increased. The macrophage-rich
inflammatory infiltrates were more cellular and were consistent with
poorly formed granulomas (Figure 1A)
. Apoptotic cells were
more numerous throughout the liver including many that were adjacent to
the poorly formed granulomas. The ballooning cell injury of the
hepatocytes was notably reduced. On day 9, extensive partially
confluent foci of necrosis of contiguous hepatocytes were observed,
predominantly in the midzone (Figure 1B)
. The sinusoidal spaces in the
areas of necrosis were widened and formed a peliosis-like configuration
but retained the sinusoidal reticulin lining as demonstrated by
reticulin and trichrome stains. Scattered neutrophils were observed in
the necrotic areas. In the nonnecrotic areas, the hepatocytes showed
diffuse microvesicular fatty metamorphosis (Figure 1C)
as well as
occasional, randomly distributed middle-sized droplet fatty change.
Occasionally, prominent large vacuoles were observed in Kupffer cells
with displacement of the nucleus that gave the cells a signet-ring
appearance. Erythrophagocytosis was observed diffusely.
|
|
|
|
Immunolocalization of IOE with Anti-E. chaffeensis Polyclonal Antibody
On days 2 and 5, no organisms were detected immunohistochemically
in any of the organs. On days 7 and 9, the liver showed morulae located
mostly in cells lining the sinusoidal spaces consistent with Kupffer
cells and/or endothelial cells and in macrophages in the sinusoidal
lumen (Figure 5A)
. Hepatocytes also
contained organisms although less frequently than the sinusoidal cells.
On day 9, the ehrlichial inclusions were more abundant than on day 7.
The organisms were not observed in the areas of hepatic necrosis.
|
Evaluation of Apoptosis by the TUNEL Method
On day 2, minimal (less than 1 to 2 per 20 HPF) apoptotic events were detected in spleen, lungs, liver, and bone marrow. On day 5, the number of apoptotic events rose to 4 to 5 cells per 20 HPF in the bone marrow. The apoptotic cells were scattered throughout the marrow involving no particular cell type. In the liver, the number of apoptotic events was 2 to 3 per 20 HPF, and the apoptotic cells were mostly located in the sinusoids or lining these structures. No apoptotic hepatocytes were noted at this time point. In the spleen, the number of apoptotic events was 20 to 25 per 20 HPF. The apoptotic cells were present in the germinal centers and the marginal zone. In the lungs the number of apoptotic events was less than 1 per 20 HPF.
On day 7, the liver contained 12 apoptotic cells per 20 HPF, and most
of the events were located in the cells lining the sinusoids (Figure 6A)
. Scattered apoptotic hepatocytes were
also present (Figure 6A)
. The foci of hepatocellular necrosis were
indeed not apoptotic. In the lungs and bone marrow, the quantity of
apoptotic cells was 0 to 1 per 20 HPF, which was similar to day 5.
However, in the spleen the quantity of apoptotic cells increased to 30
to 40 per 20 HPF (Figure 6B)
. The location of apoptotic cells was
similar to that on day 5.
|
Ultrastructural Observations
Ehrlichial inclusions (morulae) in different stages of development
were observed in spleen, liver, and lungs on days 7 and 9. On day 7
ehrlichiae were localized mostly in perisinusoidal macrophages in the
spleen. Large host cell vacuoles or morulae (3 to 5 µm in diameter),
predominantly filled with dense-cored ehrlichiae suspended in dense
intramorular matrix, were present in the cytoplasm of these cells
(Figure 7)
. Rarely, macrophages were
observed with smaller morulae containing few large reticulate
ehrlichial cells. Some of the macrophages infected with ehrlichiae
contained apoptotic bodies (fragments of other cells), phagocytized red
blood cells, other phagolysosomes, and short cisterns of granular
endoplasmic reticulum (Figure 7, A and B)
. Elongated dense-cored
ehrlichiae showed constrictions in their central region, suggesting
that they were undergoing binary fission. On day 9 infected macrophages
revealed nuclear condensation consistent with the initial stages of
apoptosis (Figure 7C)
.
|
|
|
The number of platelets and white blood cells decreased
significantly during days 7 and 9 after infection (Table 1)
. The red blood cell mass did not
reveal any significant differences during the experimental intervals or
with respect to the control animals.
|
One animal from each experimental group was evaluated. Aspartate
aminotransaminase levels rose during days 7 and 9 after inoculation
(712 and 816 IU/dl, respectively), and the elevation of alanine
aminotransaminase levels was less pronounced (Table 2)
. Both alkaline phosphatase and
bilirubin concentrations were within the normal range.
|
The serological titers on day 2 remained <1:20. On days 5, 7, and 9, the titers were elevated at 1:320, 1:160, and 1:80, respectively.
| Discussion |
|---|
|
|
|---|
Although humans have been documented to become infected with at least four species of Ehrlichia, namely E. chaffeensis, E. phagocytophila, E. ewingii, and E. canis8,9,11,13,18,28,29 , some persons portray the diseases as essentially the same. This concept is not true, and some of the conclusions are based on inappropriately interpreted serological data. Although the severity of the different ehrlichioses ranges from asymptomatic to fatal, it should be recognized that infection with E. chaffeensis is frequently severe, potentially fatal, even in immunocompetent persons, and unlikely ever asymptomatic. In contrast, Ehrlichia canis has been isolated from the blood of a healthy person.30 Ehrlichia ewingii has been associated with illness principally in immunocompromised persons.29 Asymptomatic development of antibodies reactive with E. chaffeensis occurred in soldiers heavily exposed to the species of tick, Amblyomma americanum, that also is considered to be the most likely carrier of E. ewingii and an unnamed Ehrlichia species that is highly prevalent in white-tailed deer.31-33 It is very likely that antibodies stimulated by these ehrlichiae cross-react with E. chaffeensis. The ehrlichial organism that has received the most attention, the agent of human granulocytotropic ehrlichiosis or E. phagocytophila, does not often cause illness as severe as HME, which is often comparable in severity to Rocky Mountain spotted fever and toxic shock syndrome.4,8,13,34 HME is well recognized to be associated with life-threatening adult respiratory distress syndrome and meningoencephalitis even in immunocompetent patients.35-39
Pulmonary manifestations of HME include cough, dyspnea, tachypnea ,and pleural effusions.7,35,39,40 Chest radiographs have shown findings that range from pulmonary infiltrates to those characteristic of the clinical condition, adult respiratory distress syndrome, which corresponds to the pathological entity, diffuse alveolar damage.35,40 A few autopsied cases of HME have revealed severe diffuse alveolar damage and prominent interstitial pneumonitis.35,37,39 Our mouse model shows histological abnormalities diagnostic of interstitial pneumonitis. Ehrlichial organisms were clearly demonstrated in endothelial cells of the alveolar capillaries, interstitial macrophages, and marginated monocytes in branches of the pulmonary arteries. These changes most likely represent the early stages of diffuse alveolar damage that did not develop fully because of the short duration of survival of the animals infected with a lethal dose of IOE. The previous animal models reported in the literature do not describe any lung pathology except for a brief description by Shibata and colleagues26 of mice infected with IOE in which ehrlichial organisms were present in mononuclear cells lining the blood vessels in the lungs. The capability of ehrlichiae to infect and grow within endothelium should expand our concept of their tropism and its pathogenetic implications. Evidence of infection of endothelial cells has not been demonstrated in humans. However, autopsy examinations of patients with HME are very scant, and full pathological evaluation of the human disease is obviously hampered. Preliminary observations by electron microscopy of a case of HME submitted to us for diagnostic immunohistochemistry did not reveal any infection of the endothelium. However, the ultrastructural study was performed under less than ideal conditions because of lack of adequate fixation and an unknown postmortem interval. Further studies are certainly needed to evaluate infection of other cell targets in HME.
One of the most common laboratory abnormalities found in humans with HME is the elevation of hepatic enzymes.7,8,11 Cholestasis has also been described in a few cases.41 Based on the few cases reported in the literature, the pathology of HME in the liver includes lymphohistiocytic infiltrates, Kupffer cell hyperplasia, focal hepatocyte death, hemophagocytosis, granulomas, and microvesicular fatty metamorphosis.42 The histological findings in our model closely resemble the findings in the liver in HME, except for the presence of multiple foci of necrosis. The explanation for the confluent hepatic necrosis that is observed on days 7 and 9 is not apparent. No thrombi were detected in our animal model although Winslow and colleagues18 reported thrombosis in hepatic vessels of E. chaffeensis-infected SCID mice with coagulative necrosis in the liver. The absence of ehrlichial organisms in the areas of hepatic necrosis, a finding also reported by Shibata and colleagues,26 is noteworthy. In our observations, the foci of hepatic necrosis were randomly distributed throughout the hepatic parenchyma, whereas Shibata and colleagues26 described necrotic areas around the central veins. In our animal model, ehrlichial organisms were identified ultrastructurally and by immunohistochemistry both in Kupffer cells and hepatocytes. Winslow and colleagues18 described E. chaffeensis in sinusoidal cells consistent with Kupffer cells, and Shibata and colleagues26 described the organisms of IOE in cells "lining small blood vessels in the liver." Elevations of aspartate aminotransaminases and alanine aminotransaminases on days 7 and 9 after inoculation clearly correlate with the histological findings of hepatic necrosis at days 7 and 9. Absence of elevation of alkaline phosphatase and total bilirubin levels also correlates with the absence of cholestasis or any evidence of obstruction of the biliary system. Another interesting observation in the liver was the presence of randomly distributed apoptotic bodies, generally away from the areas of necrosis. The apoptotic cells were consistent morphologically with Kupffer cells and hepatocytes. The pathogenesis of the apoptosis is at present unknown. Occasional apoptotic macrophages observed by electron microscopy on day 9 were found to be harboring ehrlichial morulae. However, double-staining of the tissue sections by the TUNEL method and anti-E. chaffeensis antibodies does not support the idea of apoptosis being triggered by intracellular infection by ehrlichial organisms. It would be plausible to hypothesize that apoptosis is rather a bystander phenomenon triggered by soluble factors (eg, cytokines) released from infected cells. The elucidation of the mechanisms of apoptosis in ehrlichial infections deserves future investigation.43,44
Another finding in the liver was the presence of microvesicular fatty metamorphosis observed both ultrastructurally and by routine histology. The pathogenesis of this finding is unknown, although morphologically it suggests profound hepatocyte dysfunction leading to abnormal intracellular fat metabolism.
The most prominent finding in the spleen was the expansion of the marginal zone by macrophages. Areas of the red pulp were also infiltrated by macrophages. Ultrastructural and immunohistological studies revealed ehrlichial organisms present in cells lining the splenic sinusoids. In addition, the spleen contained prominent follicular hyperplasia and germinal center formation with presence of tingible body macrophages. Prominent apoptotic bodies were observed both in the red pulp and the marginal zone. The germinal centers also revealed apoptotic bodies that were probably a normal component of the immune response and unrelated directly to the infectious process because no organisms were detected in the germinal centers either ultrastructurally or immunohistologically. Shibata and colleagues26 described similar splenic pathology except for the absence of follicular hyperplasia and germinal centers in their animals. The splenic pathology of HME is also similar to our findings in these mice. However, the human spleen differs somewhat histologically from the murine spleen in which hematopoiesis is normally present and lymphoid follicles are well delineated with a very well-defined marginal zone that is absent in humans.
The bone marrow is the best described target organ in humans affected by HME.45 Findings include hypercellularity more often than a hypocellular bone marrow and with myeloid hyperplasia in the majority of cases and granulomas in most nonfatal cases. In our animal model, involvement of the bone marrow was prominent with infection of the mononuclear cells, followed by areas of confluent necrosis, and a neutrophilic response on day 9. The cellularity remained constant throughout the course.
The absence of mature granulomas in our animal model is presumably explained by the use of a uniformly lethal dose that killed the mice at an early stage of the infection. However, we have observed granulomas in the liver and bone marrow of mice infected with sublethal doses of IOE (unpublished data).
Central nervous system manifestations are prominent in a relatively small proportion (<20%) of cases of HME and consist of stupor, seizures, confusion, signs of meningeal irritation, and coma.8,11,36 Histopathologically, there are prominent perivascular infiltrates in the meningeal and parenchymal vessels.42,46 Only one of our animals showed mild alteration in the meninges that consisted of margination of mononuclear cells in the blood vessels. No parenchymal involvement was detected.
It is also worth mentioning the presence of a strong antibody response in the infected animals when tested with E. muris as a surrogate antigen. E. muris is another member of the genus Ehrlichia and is closely related to E. chaffeensis and IOE based on 16S rRNA and GroEL gene sequence analysis. The decrease in titers on day 9 is probably a manifestation of a severely ill animal that is hours away from dying of overwhelming ehrlichial infection.
A mouse model of human granulocytotropic ehrlichiosis has been developed,47 but genetic analysis indicates that its agent, E. phagocytophila, is less closely related to E. chaffeensis than it is to Anaplasma marginale. Its proposed reclassification into the genus Anaplasma emphasizes the importance of investigation of these distinct agents in the appropriate animal models.48 The histological, immunohistochemical, and ultrastructural pathology in immunocompetent mice infected with ehrlichial organism closely related to E. chaffeensis, simulates closely the alterations produced by E. chaffeensis in humans, and therefore this animal model provides the opportunity to study the pathogenesis and immune responses in monocytotropic ehrlichiosis, using all of the tools and advantages of C57BL/6 mice.
| Acknowledgements |
|---|
| Footnotes |
|---|
Supported by a grant from the National Institute of Allergy and Infectious Diseases (AI 31431).
Accepted for publication November 10, 2000.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
N. R. Thirumalapura, H. L. Stevenson, D. H. Walker, and N. Ismail Protective Heterologous Immunity against Fatal Ehrlichiosis and Lack of Protection following Homologous Challenge Infect. Immun., May 1, 2008; 76(5): 1920 - 1930. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. L. Stevenson, E. C. Crossley, N. Thirumalapura, D. H. Walker, and N. Ismail Regulatory Roles of CD1d-Restricted NKT Cells in the Induction of Toxic Shock-Like Syndrome in an Animal Model of Fatal Ehrlichiosis Infect. Immun., April 1, 2008; 76(4): 1434 - 1444. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ismail, E. C. Crossley, H. L. Stevenson, and D. H. Walker Relative Importance of T-Cell Subsets in Monocytotropic Ehrlichiosis: a Novel Effector Mechanism Involved in Ehrlichia-Induced Immunopathology in Murine Ehrlichiosis Infect. Immun., September 1, 2007; 75(9): 4608 - 4620. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Miura and Y. Rikihisa Virulence Potential of Ehrlichia chaffeensis Strains of Distinct Genome Sequences Infect. Immun., July 1, 2007; 75(7): 3604 - 3613. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bitsaktsis and G. Winslow Fatal Recall Responses Mediated by CD8 T cells during Intracellular Bacterial Challenge Infection J. Immunol., October 1, 2006; 177(7): 4644 - 4651. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. L. Stevenson, J. M. Jordan, Z. Peerwani, H.-Q. Wang, D. H. Walker, and N. Ismail An Intradermal Environment Promotes a Protective Type-1 Response against Lethal Systemic Monocytotropic Ehrlichial Infection. Infect. Immun., August 1, 2006; 74(8): 4856 - 4864. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ismail, H. L. Stevenson, and D. H. Walker Role of Tumor Necrosis Factor Alpha (TNF-{alpha}) and Interleukin-10 in the Pathogenesis of Severe Murine Monocytotropic Ehrlichiosis: Increased Resistance of TNF Receptor p55- and p75-Deficient Mice to Fatal Ehrlichial Infection Infect. Immun., March 1, 2006; 74(3): 1846 - 1856. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Yager, C. Bitsaktsis, B. Nandi, J. W. McBride, and G. Winslow Essential Role for Humoral Immunity during Ehrlichia Infection in Immunocompetent Mice Infect. Immun., December 1, 2005; 73(12): 8009 - 8016. [Abstract] [Full Text] [PDF] |
||||
![]() |
J S. DUMLER Anaplasma and Ehrlichia Infection Ann. N.Y. Acad. Sci., December 1, 2005; 1063(1): 361 - 373. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. ISMAIL and D. H. WALKER Balancing Protective Immunity and Immunopathology: A Unifying Model of Monocytotropic Ehrlichiosis Ann. N.Y. Acad. Sci., December 1, 2005; 1063(1): 383 - 394. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. WINSLOW, C. BITSAKTSIS, and E. YAGER Susceptibility and Resistance to Monocytic Ehrlichiosis in the Mouse Ann. N.Y. Acad. Sci., December 1, 2005; 1063(1): 395 - 402. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Stone, K. Dierberg, G. Aram, and J. S. Dumler Human Monocytic Ehrlichiosis JAMA, November 10, 2004; 292(18): 2263 - 2270. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Olano, G. Wen, H.-M. Feng, J. W. McBride, and D. H. Walker Histologic, Serologic, and Molecular Analysis of Persistent Ehrlichiosis in a Murine Model Am. J. Pathol., September 1, 2004; 165(3): 997 - 1006. [Abstract] [Full Text] [PDF] |
||||